Market Place
Sourcing Support
Torrent, Zydus in co-marketing pact for liver disease drug Saroglitazar
10 Nov 2023 //
ECONOMIC TIMES
Zydus starts trial to generate data on effect of Saroglitazar in NAFLD patients
09 Jun 2023 //
ECONOMIC TIMES
NAFLD clinical trial activity catching up in Chin, lacks domestic participation
27 Dec 2022 //
INDIANPHARMAPOST
Zydus announces EPICS-IIITM phase-II(b)/III adaptive pivotal clinical trial
10 Dec 2021 //
EXPRESS PHARMA
Zydus announces EPICS-IIITM ph-II(b)/III adaptive pivotal trial of Saroglitazar
09 Dec 2021 //
EXPRESS PHARMA
European Medicines Agency grants Orphan Drug Designation to Zydus Cadila`s Saroglitazar Mg
20 Jul 2021 //
ECONOMIC TIMES
Zydus announces the approval of Saroglitazar Mg for the of Non-Alcoholic
30 Dec 2020 //
ZYDUSCADILA
Zydus Cadila receives DCGI nod for NAFLD drug Saroglitazar Mg in India
29 Dec 2020 //
ECONOMICTIMES
Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at AASLD
02 Nov 2020 //
EXPRESSPHARMA
Zydus Announces World`s First Drug for the Treatment of Non-Cirrhotic NASH
05 Mar 2020 //
PR NEWSWIRE
Cadila Healthcare files NDA with DCGI for liver disease drug Saroglitazar Mg
09 Dec 2019 //
MONEY CONTROL
Zydus Cadila files NDA for Saroglitazar Magnesium
05 Dec 2019 //
THE ECONOMIC TIMES
Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial
03 Oct 2019 //
BIOSPACE
Zydus completes ph III trial in India of saroglitazar Mg in type2 diabetes
01 Aug 2019 //
PHARMABIZ
Zydus Announces Regulatory Approval of Lipaglyn™ Saroglitazar Magnesium
10 Nov 2017 //
PR NEWSWIRE
Cadila Healthcare receives approval from USFDA
24 Feb 2017 //
INDIA INFO LINE
How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US
07 Jan 2017 //
ECONOMIC TIMES
The FDA`s Promo Police Slap Four More Pharmas in Year-End Enforcement Spree
30 Dec 2016 //
FIERCE PHARMA
US FDA Pulls up Cadila for Misbranding Drug
29 Dec 2016 //
ECONOMIC TIMES
Cadila Healthcare gains ahead of presenting new data of Saroglitazar
31 Oct 2016 //
BUSINESS STANDARD
India`s gliptin market ready for a shakeup by Zydus at 11 U.S. cents a pill
23 Nov 2015 //
FIERCE PHARMA ASIA
Zydus launches Tenglyn tablets in Indian market
21 Nov 2015 //
ECONOMIC TIMES
Zydus to start phase-II clinical trials for Saroglitazar in US
18 Nov 2015 //
BUSINESS STANDARD
Zydus gets US FDA nod for clinical trials of Sarolitazar
17 Nov 2015 //
DNA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.